Ten pairs of tissue samples (breast cancer and normal) were randomly distributed for MS-PCR, and 8/10 (80%) of the breast cancer tissue samples had lower methylation levels of MEST promoter versus normal adjacent tissues (Fig. 5a). This evidence concerns the gene MEST and breast cancer.